Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.69
+2.83 (19.04%)
At close: Mar 9, 2026, 4:00 PM EDT
17.50
-0.19 (-1.07%)
After-hours: Mar 9, 2026, 7:11 PM EDT
Dyne Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 893.37 | 435.45 | 121.63 | 172.15 | 200.83 | Upgrade
|
| Short-Term Investments | 217.19 | 206.82 | 1.47 | 83.87 | 175.75 | Upgrade
|
| Cash & Short-Term Investments | 1,111 | 642.27 | 123.1 | 256.01 | 376.57 | Upgrade
|
| Cash Growth | 72.91% | 421.75% | -51.92% | -32.02% | 9.05% | Upgrade
|
| Prepaid Expenses | 16.03 | 17.01 | 6.28 | 9.58 | 5.44 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.38 | Upgrade
|
| Total Current Assets | 1,127 | 659.28 | 129.38 | 265.59 | 382.39 | Upgrade
|
| Property, Plant & Equipment | 44.77 | 30.01 | 33.39 | 38.41 | 40.96 | Upgrade
|
| Long-Term Deferred Charges | 0.5 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 15.1 | 1.94 | 2.32 | 2.32 | 2.31 | Upgrade
|
| Total Assets | 1,187 | 691.23 | 165.08 | 306.33 | 425.66 | Upgrade
|
| Accounts Payable | 8.08 | 6.56 | 22.94 | 5.26 | 4.03 | Upgrade
|
| Accrued Expenses | 37.55 | 30.85 | 23.44 | 18.22 | 20.74 | Upgrade
|
| Current Portion of Leases | 5 | 4.85 | 4.72 | 4.61 | 3.89 | Upgrade
|
| Other Current Liabilities | - | - | - | 0 | 0.06 | Upgrade
|
| Total Current Liabilities | 50.63 | 42.26 | 51.1 | 28.09 | 28.72 | Upgrade
|
| Long-Term Debt | 148.92 | - | - | - | - | Upgrade
|
| Long-Term Leases | 15.28 | 19.14 | 22.7 | 25.87 | 28.74 | Upgrade
|
| Total Liabilities | 214.83 | 61.4 | 73.79 | 53.96 | 57.47 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 2,368 | 1,580 | 723.8 | 649.5 | 596.93 | Upgrade
|
| Retained Earnings | -1,396 | -949.93 | -632.51 | -396.57 | -228.47 | Upgrade
|
| Comprehensive Income & Other | 0.48 | 0.01 | - | -0.57 | -0.27 | Upgrade
|
| Total Common Equity | 972.13 | 629.84 | 91.29 | 252.36 | 368.2 | Upgrade
|
| Shareholders' Equity | 972.13 | 629.84 | 91.29 | 252.36 | 368.2 | Upgrade
|
| Total Liabilities & Equity | 1,187 | 691.23 | 165.08 | 306.33 | 425.66 | Upgrade
|
| Total Debt | 169.2 | 23.99 | 27.42 | 30.48 | 32.64 | Upgrade
|
| Net Cash (Debt) | 941.36 | 618.28 | 95.69 | 225.53 | 343.94 | Upgrade
|
| Net Cash Growth | 52.25% | 546.16% | -57.57% | -34.43% | -0.40% | Upgrade
|
| Net Cash Per Share | 7.33 | 6.57 | 1.60 | 4.34 | 6.76 | Upgrade
|
| Filing Date Shares Outstanding | 165.03 | 113.12 | 81.96 | 56.34 | 51.6 | Upgrade
|
| Total Common Shares Outstanding | 164.95 | 102.32 | 61.47 | 55.63 | 51.53 | Upgrade
|
| Working Capital | 1,076 | 617.02 | 78.28 | 237.51 | 353.67 | Upgrade
|
| Book Value Per Share | 5.89 | 6.16 | 1.49 | 4.54 | 7.15 | Upgrade
|
| Tangible Book Value | 972.13 | 629.84 | 91.29 | 252.36 | 368.2 | Upgrade
|
| Tangible Book Value Per Share | 5.89 | 6.16 | 1.49 | 4.54 | 7.15 | Upgrade
|
| Machinery | 13.45 | 11.55 | 9.64 | 8.67 | 5.2 | Upgrade
|
| Construction In Progress | 19.31 | 0.62 | 0.43 | 0.91 | 1.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.